your market intelligence analyst
Search Results
14 results
Your search is now limited to «Inflammation» expert search.
FeedNavigator (EU) 12/13/2019 02:07
Objective: This study aimed to identify the risk factors for a rapid decline in the estimated glomerular filtration rate (eGFR) in Chinese patients with type 2 diabetes and biopsy-proven diabetic kidney disease (DKD). Method: This was a retrospective cohort study. Patients with biopsy-proven DKD who had been followed-up for at least 1 year were enrolled. Baseline clinicopathological data and serum creatinine levels that had been measured at least three times during follow-up in our hospital were collected. Patients were allocated to two groups of rapid decliners and slow decliners according to the median eGFR slope. The associations between potential risk factors and rapid eGFR decline were analyzed using logistic regression. Results: A tot.
Healio News 12/11/2019 13:50
LEO Pharma announced that tralokinumab met all primary and secondary endpoints in ECZTRA 1-3, its three pivotal phase 3 studies for moderate to severe atopic dermatitis in adults. “AD is the most common inflammatory skin disease in the world with limited effective treatment options, especially for moderate to severe patients. We are encouraged that tralokinumab could potentially offer a new long-term treatment for the moderate to severe patient with AD,” Catherine Mazzacco, CEO at LEO Pharma, told Healio in an interview. Tralokinumab is an investigational, fully human monoclonal.
PROVIDENCE, R.I. (AP) - Researchers at Brown University and two Rhode Island hospitals announced they are researching a new drug to treat Alzheimer's disease. Brown, Butler Hospital and The Miriam Hospital are starting a phase-one clinical trial of emtricitabine, the three institutions announced Monday. The drug, sold under the name ...
Ubergizmo 12/08/2019 21:19
In our heads, there exists what is known as the blood-brain barrier which is a border that separates circulating blood from the brain. This in turn also prevents molecules or infectious organisms in our blood to leak into our brain, but the problem is that as we age, scientists have discovered that this barrier gets weaker, which causes chemicals to leak into our brain resulting in inflammation that leads to […]
Fight Aging! 12/08/2019 09:59
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out more: Contents The Catalytic Antibody Approach to Amyloid Aggregation This Giving Tuesday, Support Re.

Agribusiness Economics

Business Issues

Companies - Public

Companies - Venture Funded

Agricultural Equipment

Chemicals - Agricultural

Chemicals - Industrial

Commodity Prices

Farm Financial Services

Farming, Forestry, Fisheries

Financial Results

Food and Human Nutrition

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities

Products - Animal

Products - Forest

Products - Plant


Strategic Scenarios




On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications